Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study of Oral AT2101 in Treatment-naive Patients With Gaucher Disease

This study has been completed.
Sponsor:
Information provided by:
Amicus Therapeutics
ClinicalTrials.gov Identifier:
NCT00446550
First received: March 9, 2007
Last updated: May 12, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 12, 2011